Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.

Investors interested in arranging a meeting with the Company's management during the conference can register on the BIO CEO & Investor Conference website here.

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...

Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) climbed 5.5% Tuesday as the U.S. Food and Drug Administration approved ...

Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

Altria Group Inc. chief executive Billy Gifford told tobacco analysts it "has become clear that two markets exist in the U.S.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while ...

The website changes raise concerns about “the interference of politics with the study and the practice” of science and ...

CEO of Campaign for Tobacco-Free Kids. The FDA sent their final version of the regulation to the White House's Office of Management and Budget in October 2023, which then awaited a sign off from ...